Arrowhead Research reported $38.28M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Alnylam Pharmaceuticals ALNY:US $ 187.63M 32.92M
Anika Therapeutics ANIK:US $ 39.54M 1.39M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Arrowhead Research ARWR:US $ 38.28M 7.61M
Bluebird Bio BLUE:US $ 22.68M 15.2M
Dicerna Pharmaceuticals DRNA:US $ 62.95M 21.62M
Heron Therapeutics HRTX:US $ 23.23M 0.79M
Intercept Pharmaceuticals ICPT:US $ 92.83M 3.75M
IONIS PHARMACEUT IONS:US $ 133M 7.25M
Ligand Pharmaceuticals LGND:US $ 64.83M 19.84M
Merk MRK:US $ 13154M 1752M
Mirati Therapeutics MRTX:US $ 71.79M 71.79M
Moderna Inc MRNA:US 4.97B 615M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Novartis NOVN:VX SF 13367M 73M
Opko Health OPK:US $ 385.81M 56.6M
Sarepta Therapeutics SRPT:US $ 189.41M 25.32M
Tg Therapeutics TGTX:US $ 2.03M 0.48M
Ultragenyx Pharmaceutical RARE:US $ 81.65M 5.33M
Vertex Pharmaceuticals VRTX:US $ 1984.16M 190.79M
Xencor XNCR:US $ 19.68M 47.76M
YTE INCY:US $ 812.99M 107.28M